Home/Filings/4/0000899243-22-008634
4//SEC Filing

Lesser Brian Andrew 4

Accession 0000899243-22-008634

CIK 0001538927other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:10 PM ET

Size

7.6 KB

Accession

0000899243-22-008634

Insider Transaction Report

Form 4
Period: 2022-02-28
Lesser Brian Andrew
SVP, Commercial Officer
Transactions
  • Award

    Common Stock

    2022-02-28+25,00042,593 total
  • Award

    Stock Option (Right to Buy)

    2022-02-28+37,50037,500 total
    Exercise: $9.86Exp: 2032-02-27Common Stock (37,500 underlying)
Footnotes (2)
  • [F1]These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
  • [F2]25% of the shares subject to the stock option shall vest on February 28, 2023, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.

Issuer

Forma Therapeutics Holdings, Inc.

CIK 0001538927

Entity typeother

Related Parties

1
  • filerCIK 0001894291

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:10 PM ET
Size
7.6 KB